Luoquan Ao

1.3k total citations · 1 hit paper
22 papers, 765 citations indexed

About

Luoquan Ao is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Luoquan Ao has authored 22 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Luoquan Ao's work include Mesenchymal stem cell research (6 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Luoquan Ao is often cited by papers focused on Mesenchymal stem cell research (6 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Luoquan Ao collaborates with scholars based in China, United States and Hong Kong. Luoquan Ao's co-authors include Xiang Xu, Wei Xing, Xiaofeng Wu, Wei Guo, Mengwei Yao, Xiang Ao, Xueting Hu, Zhan Li, Yu Yang and Chengxiu Pu and has published in prestigious journals such as Nature Communications, Diabetologia and British Journal of Pharmacology.

In The Last Decade

Luoquan Ao

19 papers receiving 756 citations

Hit Papers

METTL3/IGF2BP3 axis inhibits tumor immune surveillance by... 2022 2026 2023 2024 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luoquan Ao China 13 505 248 181 144 93 22 765
Selma Maacha United States 10 579 1.1× 315 1.3× 231 1.3× 212 1.5× 135 1.5× 15 951
Yingjie Nie China 16 291 0.6× 152 0.6× 159 0.9× 260 1.8× 90 1.0× 41 714
Yanwen Yang China 15 430 0.9× 196 0.8× 170 0.9× 164 1.1× 30 0.3× 40 716
Juan Luis Callejas‐Valera United States 12 299 0.6× 97 0.4× 225 1.2× 121 0.8× 56 0.6× 19 693
Changjiang Feng China 16 466 0.9× 350 1.4× 65 0.4× 90 0.6× 130 1.4× 29 770
Jin Shao United States 18 673 1.3× 180 0.7× 88 0.5× 82 0.6× 172 1.8× 42 1.0k
Karlien Kallmeyer South Africa 10 211 0.4× 131 0.5× 207 1.1× 69 0.5× 86 0.9× 10 557
Anna Lokajczyk France 13 302 0.6× 93 0.4× 136 0.8× 167 1.2× 78 0.8× 18 639
Donatello Castellana Spain 9 521 1.0× 329 1.3× 144 0.8× 158 1.1× 28 0.3× 9 816
Kati Räsänen Finland 12 321 0.6× 197 0.8× 410 2.3× 115 0.8× 27 0.3× 18 754

Countries citing papers authored by Luoquan Ao

Since Specialization
Citations

This map shows the geographic impact of Luoquan Ao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luoquan Ao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luoquan Ao more than expected).

Fields of papers citing papers by Luoquan Ao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luoquan Ao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luoquan Ao. The network helps show where Luoquan Ao may publish in the future.

Co-authorship network of co-authors of Luoquan Ao

This figure shows the co-authorship network connecting the top 25 collaborators of Luoquan Ao. A scholar is included among the top collaborators of Luoquan Ao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luoquan Ao. Luoquan Ao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Xueting, Chengxiu Pu, Luoquan Ao, et al.. (2025). Lactylation-driven METTL3 regulates wound healing by enhancing m6A/HNRNPA2B1/DNMT1 signaling in keratinocytes. Genes & Diseases. 13(3). 101787–101787.
2.
Liu, Lu, Weijun Wan, Yilin Chang, et al.. (2025). Crosstalk between heterogeneous cancer-associated fibroblast subpopulations and the immune system in breast cancer: key players and promising therapeutic targets. Journal of Experimental & Clinical Cancer Research. 44(1). 263–263. 2 indexed citations
3.
Ao, Luoquan, et al.. (2025). NINJ1 impairs the anti-inflammatory function of hUC-MSCs with synergistic IFN-γ and TNF-α stimulation. Chinese Journal of Traumatology. 28(4). 276–287.
4.
He, Min, Xiang Ao, Yu Yang, et al.. (2024). Construction of self-driving anti-αFR CAR-engineered NK cells based on IFN-γ and TNF-α synergistically induced high expression of CXCL10. Neoplasia. 58. 101065–101065. 4 indexed citations
5.
Chen, Quan, Weijun Wan, Juan Li, et al.. (2024). Decoding the prognostic landscape of LUAD: the interplay between N6-methyladenosine modification and immune microenvironment. Frontiers in Immunology. 15. 1514497–1514497.
6.
Ao, Luoquan, Wei Xing, Li Zhan, et al.. (2024). WTAP/YTHDF1-mediated m6A modification amplifies IFN-γ-induced immunosuppressive properties of human MSCs. Journal of Advanced Research. 71. 441–455. 11 indexed citations
7.
Hu, Xueting, Xiaofeng Wu, Luoquan Ao, et al.. (2024). The GRHL3-regulated long non-coding RNA lnc-DC modulates keratinocytes differentiation by interacting with IGF2BP2 and up-regulating ZNF750. Journal of Dermatological Science. 113(3). 93–102. 2 indexed citations
9.
Ao, Xiang, Mei Huang, Wei Xing, et al.. (2023). Lavender essential oil accelerates lipopolysaccharide‐induced chronic wound healing by inhibiting caspase‐11‐mediated macrophage pyroptosis. The Kaohsiung Journal of Medical Sciences. 39(5). 511–521. 12 indexed citations
10.
Wan, Weijun, Xiang Ao, Quan Chen, et al.. (2022). METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer. Molecular Cancer. 21(1). 60–60. 276 indexed citations breakdown →
11.
Yao, Mengwei, Zhuo Chen, Xiao He, et al.. (2022). Cross talk between glucose metabolism and immunosuppression in IFN-γ–primed mesenchymal stem cells. Life Science Alliance. 5(12). e202201493–e202201493. 18 indexed citations
12.
Wang, Xiaohui, Wei Guo, Wei Qiu, et al.. (2022). Fibroblast-like cells Promote Wound Healing via PD-L1-mediated Inflammation Resolution. International Journal of Biological Sciences. 18(11). 4388–4399. 20 indexed citations
13.
Ao, Xiang, Luoquan Ao, Xiaofeng Wu, et al.. (2021). TNF-α augments CXCL10/CXCR3 axis activity to induce Epithelial-Mesenchymal Transition in colon cancer cell. International Journal of Biological Sciences. 17(11). 2683–2702. 47 indexed citations
14.
Guo, Wei, Wei Qiu, Xiang Ao, et al.. (2020). Low‐concentration DMSO accelerates skin wound healing by Akt/mTOR‐mediated cell proliferation and migration in diabetic mice. British Journal of Pharmacology. 177(14). 3327–3341. 28 indexed citations
15.
16.
Li, Xiangyun, Xiang Xu, Brian J. Leibowitz, et al.. (2020). eIF4E S209 phosphorylation licenses myc- and stress-driven oncogenesis. eLife. 9. 26 indexed citations
17.
Hu, Xueting, Wei Xing, Yan Tan, et al.. (2020). HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer. Journal of Experimental & Clinical Cancer Research. 39(1). 270–270. 89 indexed citations
18.
Zhan, Li, Yuqing Song, Wei Guo, et al.. (2020). Antibacterial Fusion Protein BPI21/LL-37 Modification Enhances the Therapeutic Efficacy of hUC-MSCs in Sepsis. Molecular Therapy. 28(8). 1806–1817. 17 indexed citations
19.
Zhu, Ming, Xiao He, Xiaohui Wang, et al.. (2017). Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications. Diabetologia. 60(9). 1822–1833. 21 indexed citations
20.
Ren, Dan‐ni, Jingxiao Chen, Zhi Li, et al.. (2015). LRP5/6 directly bind to Frizzled and prevent Frizzled-regulated tumour metastasis. Nature Communications. 6(1). 6906–6906. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026